Pathology

Doç. Dr. Tülay Zenginkinet

Doctor and researcher Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi İstanbul
Skin NeoplasmsHamartoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Skin Neoplasms 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Hamartoma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionGöztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesisaglik.gov.trFrom source
  • Area of workSkin NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications45 publicationsOpenAlex, Europe PMCFrom source
  • ORCID0000-0003-3056-2074ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://suleymanyalcinsh.saglik.gov.tr/TR-1493897/doktorlarimiz.html#tulay-zenginkinetsaglik.gov.tr

Scientific work

Publications on Skin Neoplasms

45 publications

  1. The Preconditioning Effect of Normobaric Hyperoxia on Postoperative Cognitive Dysfunction After Repeated Anesthesia in Rats

    Journal of Anesthesiology and Reanimation Specialists’ Society, 2026

    DOI 10.54875/jarss.2026.04696 Open-access full textSource: OpenAlex

  2. Amniotic Membrane for Tympanic Membrane Repair: An Experimental Study

    The journal of international advanced otology, 2026

    DOI 10.65717/iao.2026.262437 PMID 42732620 Open-access full textSource: Europe PMC

  3. Effects of ketamine and dexmedetomidine on ischemia‑ reperfusion injury in an experimental renal ischemia model

    Experimental and Therapeutic Medicine, 2026

    DOI 10.3892/etm.2026.13302 PMID 42846694 Open-access full textSource: OpenAlex

  4. Results of amputation after limb salvage surgery and primary amputation after diagnosis in malignant bone and soft tissue tumours

    International Journal of Orthopaedics and Traumatology, 2023

    DOI 10.33545/26648318.2023.v5.i1a.23 Open-access full textSource: OpenAlex

  5. Evaluation of PD-L1 expression in recurrent nonmetastatic sacral chordomas - a retrospective study

    Srpski arhiv za celokupno lekarstvo, 2023

    DOI 10.2298/sarh220524009z 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. The Impact of COVID-19 Pandemic Restrictions on Musculoskeletal Pathology Services

    Cureus, 2023

    DOI 10.7759/cureus.39493 PMID 37362477 Open-access full textSource: OpenAlex

  7. Programmed cell death ligand-1 (PD-L1) expression in desmoid tumors: a retrospective study.

    PubMed, 2023

    DOI 10.26355/eurrev_202306_32640 PMID 37318496 2 citations (Europe PMC) Source: OpenAlex

  8. COVID-19 pandemisinin deri kanseri tanısına etkisi: Tek Merkezli Çalışma

    DergiPark (Istanbul University), 2023

    Open-access full textSource: OpenAlex

  9. Histopathological results of adenoidectomy and/or tonsillectomy: 14 years of experience

    Medicine Science | International Medical Journal, 2023

    DOI 10.5455/medscience.2023.08.151 Open-access full textSource: OpenAlex

  10. PD-L1 Status in Tenosynovial Giant Cell Tumors

    Medicina, 2022

    DOI 10.3390/medicina58091270 PMID 36143947 4 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 45 publications